INVESTMENT IN TNF PHARMACEUTICALS, INC. (Details - Preferred stock) |
9 Months Ended |
|---|---|
|
Jan. 31, 2025
USD ($)
| |
| Series G Preferred Stock [Member] | |
| Fair value of financial assets at beginning | $ 0 |
| Fair value of investment, purchases | 17,410,050 |
| Change in fair value of investment | (1,642,050) |
| Fair value of financial assets at ending | 15,768,000 |
| Preferred Stock Warrants [Member] | |
| Fair value of financial assets at beginning | 0 |
| Fair value of investment, purchases | 10,985,684 |
| Change in fair value of investment | (8,123,684) |
| Fair value of financial assets at ending | $ 2,862,000 |
| X | ||||||||||
- Definition Fair value portion of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|